Cocrystal Pharma (COCP) Interest Coverage Ratio (2010 - 2026)
Cocrystal Pharma (COCP) reported Interest Coverage Ratio of 107.09 for Q1 2026, up 69.26% on a YoY basis from 63.27 in Q1 2025, and up 1619.39% sequentially from 7.05 in Q4 2025.
Cocrystal Pharma (COCP) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 17 years of Interest Coverage Ratio data on file, last reported at 107.09 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 69.26% year-over-year to 107.09; the trailing twelve-month figure through Mar 2026 stood at 31.15 (down 38.52% YoY), and the FY2025 full-year result was 13.38, up 40.95% from the prior year.
- Interest Coverage Ratio rose to 107.09 in Q1 2026, from 7.05 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 107.09 in Q1 2026 to a low of 939.54 in Q2 2022.
- A 5-year average of 68.93 and a median of 7.87 in 2025 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio sank 1299.0% in 2022 and surged 234.76% in 2025, its largest moves.
- Tracing COCP's Interest Coverage Ratio over 5 years: stood at 29.62 in 2022, then plunged by 130.12% to 8.92 in 2023, then surged by 162.1% to 5.54 in 2024, then sank by 227.22% to 7.05 in 2025, then jumped by 1619.39% to 107.09 in 2026.
- Business Quant data shows COCP's Interest Coverage Ratio at 107.09 in Q1 2026, 7.05 in Q4 2025, and 8.63 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | 107.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107.09 |
| Dec 31, 2025 | -7.05 |
| Sep 30, 2025 | -8.63 |
| Jun 30, 2025 | -7.87 |
| Mar 31, 2025 | 63.27 |
| Dec 31, 2024 | 5.54 |
| Sep 30, 2024 | -12.15 |
| Jun 30, 2024 | -2.56 |
| Mar 31, 2024 | 18.90 |
| Dec 31, 2023 | -8.92 |
| Sep 30, 2023 | 13.88 |
| Jun 30, 2023 | -23.84 |
| Mar 31, 2023 | -91.27 |
| Dec 31, 2022 | 29.62 |
| Sep 30, 2022 | -299.68 |
| Jun 30, 2022 | -939.54 |
| Mar 31, 2022 | -8.69 |
| Dec 31, 2021 | 26.07 |
| Sep 30, 2021 | -74.58 |
| Jun 30, 2021 | -67.16 |